Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.65)
# 3,704
Out of 4,829 analysts
81
Total ratings
17.91%
Success rate
-21.23%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $92 → $87 | $75.76 | +14.84% | 10 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $16.81 | +120.11% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $41.72 | +55.80% | 6 | May 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $3.5 → $2.5 | $0.37 | +572.77% | 3 | Apr 29, 2025 | |
| AKYA Akoya Biosciences | Maintains: Hold | $3.5 → $1.8 | $1.10 | +63.64% | 4 | Apr 29, 2025 | |
| GRAL GRAIL | Initiates: Buy | $32 | $35.20 | -9.09% | 1 | Apr 21, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $123.20 | +21.76% | 3 | Apr 16, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Buy | $3 | $1.12 | +167.86% | 8 | Apr 10, 2025 | |
| QTRX Quanterix | Maintains: Buy | $20 → $15 | $5.28 | +184.09% | 5 | Mar 18, 2025 | |
| NTRA Natera | Maintains: Buy | $180 → $195 | $151.95 | +28.33% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.77 | +105.25% | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $5.71 | +22.59% | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.13 | +165.49% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $1.26 | -20.63% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $51.63 | +45.26% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.50 | +300.00% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.68 | +7,115.13% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.60 | +427.78% | 1 | Jan 29, 2021 |
Illumina
May 12, 2025
Maintains: Hold
Price Target: $92 → $87
Current: $75.76
Upside: +14.84%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $16.81
Upside: +120.11%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $41.72
Upside: +55.80%
Biodesix
Apr 29, 2025
Maintains: Buy
Price Target: $3.5 → $2.5
Current: $0.37
Upside: +572.77%
Akoya Biosciences
Apr 29, 2025
Maintains: Hold
Price Target: $3.5 → $1.8
Current: $1.10
Upside: +63.64%
GRAIL
Apr 21, 2025
Initiates: Buy
Price Target: $32
Current: $35.20
Upside: -9.09%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $123.20
Upside: +21.76%
Pacific Biosciences of California
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.12
Upside: +167.86%
Quanterix
Mar 18, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $5.28
Upside: +184.09%
Natera
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $151.95
Upside: +28.33%
Feb 13, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.77
Upside: +105.25%
Jan 3, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $5.71
Upside: +22.59%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.26
Upside: -20.63%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $51.63
Upside: +45.26%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.50
Upside: +300.00%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.68
Upside: +7,115.13%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.60
Upside: +427.78%